drug · small molecule
patient view →BOSENTAN
Marketedupdated 2mo agoby $NSRX Nasus Pharma Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 23 investigational indications.
targets
Endothelin receptor, ET-A/ET-B
all catalysts(21)
approval · 21
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that